[go: up one dir, main page]

Tran et al., 2023 - Google Patents

The effectiveness of HIV drug resistance mutation testing on dried blood spot (DBS) samples in Vietnam

Tran et al., 2023

View HTML
Document ID
6743585241597254575
Author
Tran T
Doan T
Phan H
Doan X
Nguyen T
Publication year
Publication venue
Fortune Journal of Health Sciences

External Links

Snippet

Background: Over the past years, numerous countries worldwide have conducted investigations into HIV drug resistance (HIVDR) using methods recommended by the World Health Organization (WHO)[1]. In 2017, WHO launched a global action plan on HIV drug …
Continue reading at fortunescholar.org (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/04—Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor

Similar Documents

Publication Publication Date Title
Kotton et al. The fourth international consensus guidelines on the management of cytomegalovirus in solid organ transplantation
Hu et al. Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS‐CoV‐2
Tuaillon et al. Dried blood spot for hepatitis C virus serology and molecular testing
WO2008079463A2 (en) Biological organism identification product and methods
Kardjadj et al. Seroprevalence, distribution and risk factor for peste des petits ruminants (PPR) in Algeria
Gierer et al. Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia
Farasani Monkeypox virus: Future role in Human population
Vidya et al. Dried blood spots versus plasma for the quantitation of HIV-1 RNA using a real-Time PCR, m2000rt assay
Wright et al. A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa
Ibrahim et al. Brief report: high sensitivity and specificity of the Cepheid Xpert HIV-1 qualitative point-of-care test among newborns in Botswana
Raïch-Regué et al. Performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests for Omicron and other variants of concern
Ali et al. Clinical features, diagnosis and treatment of COVID-19
Allicock et al. Method versatility in RNA extraction-free PCR detection of SARS-CoV-2 in saliva samples
Denner Infectious risk in xenotransplantation–what post‐transplant screening for the human recipient?
Saeed et al. A study on transmission of Peste des petits ruminants virus between dromedary camels and small ruminants
Ishara-Nshombo et al. Diagnostic accuracy of 3 mpox lateral flow assays for antigen detection, Democratic Republic of the Congo and United Kingdom
World Health Organization Diagnostic testing and testing strategies for mpox: interim guidance, 12 November 2024
Levett et al. Evaluation of a high volume antigen test for detection of SARS-CoV-2
Tran et al. The effectiveness of HIV drug resistance mutation testing on dried blood spot (DBS) samples in Vietnam
González et al. Antibody response to SARS-CoV-2 infection over six months among Nicaraguan outpatients
Furukawa et al. Serologic evidence for hepatitis E virus infection among patients with undifferentiated acute febrile illness in Kibera, Kenya
Lilian et al. Early diagnosis of human immunodeficiency virus-1 infection in infants with the NucliSens EasyQ assay on dried blood spots
Favara et al. SARS-CoV-2 infection and antibody seroprevalence among UK healthcare professionals working with cancer patients during the first wave of the COVID-19 pandemic
Le Roy et al. Swabs (dry or collected in universal transport medium) and semen can be used for the detection of Chlamydia trachomatis using the cobas 4800 system
Pisani et al. Detection of West Nile virus RNA (lineages 1 and 2) in an external quality assessment programme for laboratories screening blood and blood components for West Nile virus by nucleic acid amplification testing